Rosuvastatin 20mg Tablet - Crestor -...

Rosuvastatin 20mg Tablet - Crestor - 1 box

Reduction of elevated total cholesterol (total-C), LDL-C, apolipoprotein B (ApoB), total-C: HDL-C ratio triglycerides & increasing HDL-C in hyperlipidemic & dyslipidemic conditions. Reduction of total mortality & risk of major CV events in adults w/ increased risk of atherosclerotic CV disease based on presence of CV disease risk markers. Primary dysbetalipoproteinemia (type III hyperlipoproteinemia); primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia & severe non-familial hypercholesterolaemia); combined (mixed) dyslipidaemia (type IIb); homozygous familial hypercholesterolaemia. Adjunctive therapy to diet to slow progression of atherosclerosis in adults as part of treatment strategy to lower total-C & LDL-C to target levels. Adjunct to diet to reduce total-C, LDL-C & ApoB levels in adolescents at least 1 yr post-menarche, 10-17 yr w/ heterozygous familial hypercholesterolaemia.

 

Active Ingredient

  • Rosuvastatin Ca 20mg

Indication/Use

  • Individualized dosage. Usual initial dose: 10 mg once daily
  • Patient requiring less aggressive LDL-C reductions Initially 5 mg once daily. Dose adjustments can be made after 4-wk interval. Max response is usually achieved w/in 2-4 wk & maintained during chronic therapy.
  • Severe hypercholesterolemia at high CV risk Increase dose to 40 mg
  • Ped patient 10-17 yr Heterozygous familial hypercholesterolemia 5-20 mg daily. Dose adjustments should be made at ≥4-wk interval. Max dose: 20 mg daily. Asian patient Initially 5 mg once daily
  • Predisposing factors to myopathy Recommended starting dose: 5 mg. Severe renal impairment 5 mg once daily. Not to exceed 10 mg once daily
P02002194
No reviews

Grade Comments (0)

No customer reviews for the moment.
Product added to wishlist
Product added to compare.

This site uses cookies to personalize your experience, analyze site traffic and keeps track of items stored in your shopping basket.

By clicking ACCEPT or continuing to browse the site, you are agreeing to our use of cookies. See our Privacy Policy here for more details